Doxazosin Mesylate 59762-1391
Product NDC
59762-1391- Manufacturer
- Mylan Pharmaceuticals Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 9, 2025
- Listing Expires
- December 31, 2026
- Application
- NDA019668
Need to source Doxazosin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Doxazosin Mesylate | 8 mg/1 |
Drug Class
Adrenergic alpha-Antagonists [MoA]alpha-Adrenergic Blocker [EPC]